Healthcare provider profile · identity verified

Vijay Singh, M,D,

Internal Medicine · READING, PA · NPI 1023016755

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	423	125
Levothyroxine Sodium	Levothyroxine Sodium	405	102
Amlodipine Besylate	Amlodipine Besylate	404	108
Lisinopril	Lisinopril	260	79
Metformin Hcl	Metformin Hcl	247	75
Tamsulosin Hcl	Tamsulosin Hcl	217	59
Losartan Potassium	Losartan Potassium	205	60
Metoprolol Succinate	Metoprolol Succinate	184	51
Omeprazole	Omeprazole	180	60
Metformin Hcl Er	Metformin Hcl	174	50
Glimepiride	Glimepiride	164	44
Pantoprazole Sodium	Pantoprazole Sodium	153	42
Simvastatin	Simvastatin	149	41
Januvia	Sitagliptin Phosphate	143	30
Furosemide	Furosemide	139	56
Pravastatin Sodium	Pravastatin Sodium	136	40
Hydrochlorothiazide	Hydrochlorothiazide	130	31
Metoprolol Tartrate	Metoprolol Tartrate	128	40
Eliquis	Apixaban	127	32
Gabapentin	Gabapentin	121	40
Potassium Chloride	Potassium Chloride	111	26
Allopurinol	Allopurinol	103	25
Tramadol Hcl	Tramadol Hcl	102	31
Alprazolam	Alprazolam	96	30
Bisoprolol Fumarate	Bisoprolol Fumarate	89	28
Albuterol Sulfate Hfa	Albuterol Sulfate	88	27
Ezetimibe	Ezetimibe	87	25
Valsartan	Valsartan	85	25
Hydralazine Hcl	Hydralazine Hcl	76	19
Pioglitazone Hcl	Pioglitazone Hcl	72	23
Sertraline Hcl	Sertraline Hcl	72	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	17
Zolpidem Tartrate	Zolpidem Tartrate	63	21
Farxiga	Dapagliflozin Propanediol	62	suppressed
Clopidogrel	Clopidogrel Bisulfate	57	13
Jardiance	Empagliflozin	56	13
Trazodone Hcl	Trazodone Hcl	56	suppressed
Alendronate Sodium	Alendronate Sodium	55	19
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	51	17
Carvedilol	Carvedilol	47	20
Meloxicam	Meloxicam	46	19
Rosuvastatin Calcium	Rosuvastatin Calcium	44	15
Citalopram Hbr	Citalopram Hydrobromide	40	14
Mirtazapine	Mirtazapine	40	11
Enalapril Maleate	Enalapril Maleate	39	11
Finasteride	Finasteride	39	12
Warfarin Sodium	Warfarin Sodium	39	11
Atenolol	Atenolol	38	suppressed
Famotidine	Famotidine	38	14
Lorazepam	Lorazepam	34	13
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Fenofibrate	Fenofibrate	33	suppressed
Fenofibrate	Fenofibrate,micronized	33	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	13
Azithromycin	Azithromycin	30	29
Fluticasone Propionate	Fluticasone Propionate	30	13
Buspirone Hcl	Buspirone Hcl	29	suppressed
Clonazepam	Clonazepam	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	27
Benazepril Hcl	Benazepril Hcl	27	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	27	27
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Jantoven	Warfarin Sodium	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Methylprednisolone	Methylprednisolone	23	18
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Cilostazol	Cilostazol	20	suppressed
Irbesartan	Irbesartan	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Ramipril	Ramipril	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Veltassa	Patiromer Calcium Sorbitex	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Glipizide Er	Glipizide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Glipizide	Glipizide	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Diazepam	Diazepam	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	12
Lokelma	Sodium Zirconium Cyclosilicate	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Colesevelam Hcl	Colesevelam Hcl	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Prednisone	Prednisone	11	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error